Skip to content
55

sulforaphan

Worth a look

Shows low returns (0.1%), but soft demand (-5.9% this quarter) keeps it on the watch list.

Market size 46Growth 22Conversion 84Competition 27Returns 99Price range 94Avg price 90Brand share 47Review moat 78Quality gap 48

Returns

Incredible0.1%

return rate — above 5% kills the launch gate

Price range

Great€14.78–€35.69

cheapest to priciest tracked listing — scored on the share inside $15–$100

Avg price

Great€20.80

avg listing price — sweet spot $15–$100

Conversion

Great9.3%

search→purchase rate — share of searches ending in a sale

Review moat

Great449.07

avg incumbent reviews — the moat a new listing must climb

Quality gap

Okay4.5★

avg incumbent rating — lower means beatable quality

Brand share

Okay77%

top-5 brand share — brands hold most of the demand

Market size

Okay€247K

€247K/yr · 128K searches

Competition

Okay69%

top-5 click share — leaders hold, buyers still browse

Growth

Bad-5.9%

90-day search growth — must beat 0% to launch

Reviews